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Familial amyloid angiopathy, or hereditary cerebral hemorrhage with amyloid-
osis in patients from Iceland (HCHWA-I)', is an autosomal dominant form ofam-
yloidosis that leads to hemorrhagicand thrombotic strokes causing death before the
age of40 yr (1-3). 128 affected members in eight families originating from the same
geographic area in Iceland have been identified. The histopathology ofHCHWA-I
brains demonstrates generalized amyloid angiopathy, similar tocases with HCHWA
of Dutch origin (4) and cases ofAlzheimer disease, but they are unassociated with
neuritic plaques or tangles (2, 5). The amyloid protein extracted from leptomeninges
vessel wall ofpatients with HCHWA-I was shown to be a variant ofcystatin C (6).
Very recently, amyloid deposits were also found in tissues outside thecentral nervous
system (7).
Human cystatin C (8) (previous nomenclature: ,y-CSF [9], post--y protein [10],
T-trace [11], and post-gamma globulin [12]) is a low-molecular mass protein shown
to be a potent inhibitor of lysosomal cysteine proteinases (8, 13) . It is present in
many tissues and all body fluids (13-15). Cystatin C is secreted into tissue culture
media by monocytes as well as by several primary cells, including brain cells and
diverse established cell lines. It was suggested that downregulation of its secretion
by monocytes may play a role in inflammation (16) . The superfamily of cysteine
proteinase inhibitors encompasses at least three distinct families: the stefins, cys-
tatins, and kininogens (17, 18). The cystatin C protein isolated from the cerebro-
vascular amyloid was found to lack the first 10 NH2-terminal amino acid residues
and one amino acid substitution was demonstrated to be present at position 68
(glutamine for leucine), when compared with urinary cystatin C (19). The cystatin
C concentration in the cerebrospinal fluid in patients with HCHWA-I is abnormal-
ly low (14). It is conceivable that a mutation had occurred leading to the production
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of an unusual cystatin C protein that is abnormally degraded, bound, and/or pre-
cipitated . To clarify this point, genomic DNA libraries were constructed from nor-
mal human tissue and from the brain of an Icelandic patient with HCHWA-I. The
gene encoding cystatin C was isolated from both libraries and sequenced. A pre-
liminary study has already been reported (20).
Materials and Methods
The normal human cystatin C gene was previously isolated from a human genomic DNA
library constructed from high molecular weight genomic DNA prepared as described (21)
and cloned into abacteriophage A charon 4A vector (20, 22). A second human genomic DNA
library was prepared from the brain of an Icelandic female with HCHWA who died at the
age of 38 yr (GG) (19). 20-kb DNA fragments were generated by partial Sau 3AI digestion
ofthe genomic DNA. The isolated arms of X EMBL4 DNA (Promega Biotec, Madison, WI)
generated by digestion with Barn HI were ligated with the fragmented DNA and packaged
into bacteriophage X particles using an in vitro packaging system (Stratagene, LaJolla, CA).
About 3 x 105 recombinant bacteriophage from both libraries were screened by low strin-
gency hybridization with synthetic oligonucleotides after replica plating onto nitrocellulose
filters (23). The oligonucleotides were 5'-labeled with y-["P]ATP and T4 polynucleotide ki-
nase as described (24). Approximately 5 x 105 cpm/ml of radioactive oligonucleotide probe
was used for hybridization (20). Hybridized filters were washed to a final stringency of0.2 x
SSC, 0.1% at 42°C (1 x SSC = 0.15 M NaCl, 0.015 M Na-3 citrate, pH 7.5).
Oligonucleotides were chosen on the basis of the amino acid sequence of human cystatin
C (14, 19). Where the amino acid sequence did not allow the unambiguous selection of nu-
cleic acid residues, the actual choice of nucleotide sequence was based on the codnn bias ob-
served in a number of human mRNA sequences (25). Three oligonucleotides, a 33-mer cor-
respondingto a sequence coding for amino acids 33-43, a 31-mer encoding amino acids 81-91,
and a 30-mer encoding amino acids 102-111, were synthesized. Positively hybridizing clones
were plaque purified and DNA prepared . The extent of sequences encoding the human cys-
tatin C gene was determined by restriction mapping and Southern blotting (26) using the
three oligonucleotides as probes (20). Fragments specifically hybridizing with each ofthe probes
were subcloned into pUC18 or directly into M13 .
Exonuclease Bal 31 was used as described (27) to generate a set of overlapping deleted
fragments from each subclone, which were cloned into bacteriophage M13 and sequenced
by the dideoxy-chain termination method (28) with sequenase (United States Biochemical
Corp., Cleveland, OH) (29). Sequence information obtained from the normal cystatin C gene
enabled direct subcloning of the variant DNA fragments from bacteriophage X into bacterio-
phages M13. Identification ofrestriction fragments for subcloning and sequencingwas deter-
mined by hybridization of the labeled oligonucleotides to dried agarose gels (30).
Results and Discussion
Sequences coding for human cystatin C were previously isolated from a human
genomic library cloned into bacteriophage A. Restriction maps of the X clones con-
taining the normal human cystatin C gene (20) facilitated the subcloning of frag-
ments for sequence analysis . The three synthetic oligonucleotide probes detected
three noncontiguous fragments (as indicated in Fig. 1), contained within a Hind
III restriction fragment of 9 .5 kb. The 1.5-kb Hind III/Bgl II fragment detected
by the 33-mer probe and the 2.8-kb Bgl II/Bam HI fragment detected by the 30-mer
probe were subcloned into pUC18 for sequence analysis. The 500-bp Eco RI/Pst
I fragment giving positive hybridization with the 31-mer probe was directly sub-
cloned into M13mp8 and sequenced (20). The regions sequenced are indicated in
Fig. 1; the sequence data are shown in Fig. 2 together with the encoded amino acidH
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FIGURE l.
￿
Restriction mapof theHind III fragment containing thecystatin C gene. Restriction
enzymes shown are: Bam HI (B), Bgl II (Bg), Eco RI (E), Hind III (H), Kpn I (K), and Pst
I (P). The positions ofcystatin C coding sequences areindicated by filled boxes. The threefrag-
ments subcloned for further analysis are indicated by brackets. Arrows (-4--10-) delineate the
regions of the human cystatin C sequenced. Arrows (.4--- 10.) delineate the regions sequenced
from the genomic DNA derived from the HCHWA-I patient.
sequence. Comparison of sequences with the amino acid sequence ofcystatin C allows
the reading frame to be established unambiguously. This alignment also allows the
localization of the splice acceptor and donor sites of the three cystatin C exons.
Thecystatin C gene encodes a polypeptideof 146 amino acids. The first 26 amino
acidsencoded by the open reading frame specify asecretory peptide signal sequence
(31). The gene contains two intervening sequencds that interrupt the coding region
at amino acids 55 and 93. The Kozak initiation consensus (32) sequence abuts the
probable ATG initiator codon. A putative TATA motif, ATAAA, which is common
to a large number of eukaryotic promoters, is present 119 by upstream to the ATG
start codon. 241 by downstream to the TAG stop codon, there is the hexanucleotide
AATAAA, aconsensus polyadenylation signal that precedes the site of polyadenyla-
tion in many eukaryotic cellular mRNAs (33).
The 5' region, upstream from the TATA box, is remarkable for its high content
of G residues (58%), which frequently occur as long uninterruptedtracts. In agree-
ment with sequence data forcystatin SN (34), this region is highly purine rich (N83%
A+G). A 31-bpdirect repeat sequence occurs at nucleotides -257 to -226 and -238
to -207 relative to the ATG start codon. Twice in the 5' untranslated sequence, at
position -730, as well as -146, areheptamer sequences that are high affinity binding
sites forthe transcription factor Spl (35, 36). Interestingly, the promoter ofthe ham-
ster PrP gene, the product of which gives rise to brain amyloid deposits in scrapie-
infected animals, also contains three potential bindingsitesfor the transcription factor
Spl (37). The sequence TGGGG is repeated many times in the cystatin C gene,
including 12 times in the 5' untranslated region. Although the significance of this
sequence is unknown, it has been observed that this pentamer is present three times
in a 27-base-long DNA synthetic oligonucleotide, which binds in vitro to duplex
DNA at a single site within the 5' end of the human c-myc gene, resulting in the
repression ofc-myctranscription (38). The sequence GGGGTGGGG is present three
times in the 5' untranslated region ofthecystatin C gene and once in the 3' flanking
region of the third exon. This CACCC box is predominantly found in globin genes
in several copies, and in both orientations, and is considered an enhancer element
(39-41).
Salivary cystatins share a high degree of amino acid (34) and nucleotide (42) se-1774
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FIGURE 2.
￿
Sequence of the gene encoding thehumancystatin C. Nucleotides in the 5' untrans-
latedregion arenumbered relative to theATGstartcodon. Numberingof theamino acidsdeduced
from thenucleotide sequence starts with residue 1 ofthemature protein. Numberingof theamino
acid sequence of the secretory signal sequence is relative to the mature protein. An upstream
TATA motifand thepolyadenylation signal areunderlined, as is the site of point mutation. spl
binding sequences and a direct repeat are indicated by dashed lines. Dots indicate regions of
intervening sequencesnotsequencedandnotputto scale. Shownhere are 250nucleotides down-
stream to thepolyadenylation signal, out of 2,000 nucleotides sequenced, as indicated in Fig. 1.LEVY ET AL.
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quence homology with cystatin C. Alignment of the gene encoding cystatin C and
cystatin SN (34) for maximum homology (data not shown) demonstrates that the
salivary cystatin genes and the cystatin C gene share the same gene organization.
The two introns present in the cystatin C gene correspond precisely in location to
the two introns in the salivary cystatins.
Kitamura et al. (43) have shown that the kininogen gene is composed of eleven
exons, of which the first nine exons can be characterized by a triple repeat of three
exons. Each repeat comprises acysteine proteinase inhibitor-like domain (18). Com-
parision of our data of the cystatin C gene, as well as that of the salivary cystatins
(34) to the three repeated domains of the kininogen gene, demonstrates conserva-
tion of exon-intron structure between the cystatins and kininogen in support of the
notion that they are evolutionarily related (13, 17, 18). Comparison of our data to
the DNA sequences ofcystatin SN (34) demonstrates that the second exons ofthese
genes are especially homologous (85% sequence homology), while the first and third
exons are 68% and 69% homologous. It has been suggested that the segment be-
tween amino acids 53 and 69, located in the second exon, may be the active site
of the cysteine proteinase inhibitors, since it is themost conservedregion in all known
cystatins (8, 13).
Comparison of the sequences derived from genomic DNA also demonstrates that
these genes share a high degree of sequence homology beyond donor and acceptor
splicing sites of RNA. Thehighest homology ofuntranslated sequences (N80%) was
foundwithin the intervening sequences on both sides of thethird exon. Theseresults
place the cystatin C and the salivary cystatins in the same gene family.
The cystatin C deposited as amyloid fibrils in the wall of small blood vessels in
the brain of Icelanders showed a single amino acid substitution (glutamine instead
of leucine at position 68) (19), as compared with normal cystatin C. Sequencing of
the cystatin C variant isolated from the genomic DNA library of the HCHWA-I
patient demonstrated that the amino acid substitution is the result of apoint muta-
tion. A single base substitution was found, CAG instead of CTG, in amino acid
position 68 of the protein. This mutation abolishes an Alu I restriction site in the
cystatin C gene of HCHWA-I patients. Loss ofthis site was detected by RFLP using
Alu I restriction endonuclease and a cystatin C cDNA probe (44 and unpublished
observations). The Alu I RFLP marker was only found in HCHWA-I patients and
cosegregated with thedisease in everycase. Thenucleic acid sequence obtained from
the HCHWA-I patient was otherwise 100% homologous to the normal cystatin C
gene, in the coding as well as noncoding regions sequenced.
It was shown that the first 10 amino acids aremissingfrom the cystatin C protein
isolated from patients' amyloid (19). Since sequence analysis indicates that the 5'
end of the structural gene isolated from the HCHWA-I patient is intact, the trun-
catedcystatin C amyloid is probably caused by postranslational enzymatic cleavage.
In this context it is of interest to note that multiple salivary cysteine proteinase in-
hibitors (45, 46), as well as cystatin C obtained from urine, seminal fluid, and
cerebrospinal fluid isolated from normal individuals (unpublished observation), were
found to have heterogeneous NH2 termini. Identical untranslated regions 5' to the
normal and mutated genes argue against the possibility of aberrant promoter se-
quences, causing abnormal expression of the gene.
The variant cystatin C gene differs from the normal gene in a single nucleotide,
resulting in a single amino acid substitution in the highly conserved region of the177 6
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cystatin gene family (8, 13), increasing the hydrophilicity ofthis region in the HCHWA-
I amyloid subunit. Furthermore, the presence ofGin instead of Leu makes the pep-
tide bond Gln-Gly, a potential site for the formation of (3 hairpin type-I' (19, 47).
The mutation in the structural gene for cystatin C may be the primary defect in
this inherited disorder but its relationship to the formation and deposition of the
amyloid fibrils in HCHWA-I patients is unclear. The mutation and/or degradation
may render the cystatin C protein resistant to normal protein turnover, or alterna-
tively, create novel binding sites that may be more susceptible to proteolytic break-
down and polymerization.
Summary
Cystatin C is an inhibitor oflysosomal cysteine proteases and consists of 120 amino
acids. A variant of cystatin C lacking the first 10 NH2-terminal residues and having
one amino acid substitution at position 68 forms amyloid deposits mainly in the
walls of brain arteries, causing fatal strokes in Icelandic patients with familial cere-
bral hemorrhage secondary to a form of an autosomal dominant amyloidosis. To
understand the molecular basis of the genetic defect, the gene encoding cystatin C
was isolated from genomic DNA libraries made from normal tissue and the brain
of an Icelandic patient with hereditary cerebral hemorrhage with amyloidosis
(HCHWA-I). The data indicate that the cystatin C gene encodes a polypeptide of
146 amino acids, of which the first 26 correspond to a secretory peptide signal se-
quence. The gene contains two intervening sequences that interrupt the coding re-
gion at amino acids 55 and 93. Comparison with genes encoding salivary cystatins
and kininogen proteins show sequence homology and conservation of exon-intron
structure. Except for a mutation in the second exon (GAG instead of CTG in the
normal gene, resulting in the substitution of glutamine for a leucine residue), the
gene cloned from the brain of the Icelandic patient is identical to the normal cystatin
C gene. Thus, HCHWA-I is the first familial type of amyloidosis related to a point
mutation in a gene encoding for an inhibitor. The mutation in the structural gene
encoding cystatin C appears to be the primary defect in this inherited disorder causing
amyloid fibril formation and accumulation followed by cerebral hemorrhage.
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